BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,398,807 | +34.1% | 2,421,802 | +61.9% | 2.33% | +56.2% |
| Q2 2023 | $68,140,219 | +34.8% | 1,495,615 | +20.0% | 1.49% | +51.5% |
| Q1 2023 | $50,535,691 | +136357.6% | 1,245,949 | +71.5% | 0.99% | +57.3% |
| Q4 2022 | $37,034 | -99.9% | 726,592 | +10.7% | 0.63% | +28.0% |
| Q3 2022 | $35,348,000 | -55.3% | 656,290 | -46.7% | 0.49% | -40.1% |
| Q2 2022 | $79,068,000 | +31.2% | 1,231,006 | +58.4% | 0.82% | +27.2% |
| Q1 2022 | $60,268,000 | +30.1% | 777,256 | +44.0% | 0.64% | +38.3% |
| Q4 2021 | $46,342,000 | +237.3% | 539,863 | +216.1% | 0.46% | +232.1% |
| Q3 2021 | $13,739,000 | +83.1% | 170,814 | +83.3% | 0.14% | +97.2% |
| Q2 2021 | $7,503,000 | +236.9% | 93,205 | +253.0% | 0.07% | +238.1% |
| Q1 2021 | $2,227,000 | +81.6% | 26,400 | +72.9% | 0.02% | +23.5% |
| Q4 2020 | $1,226,000 | -84.8% | 15,273 | -84.8% | 0.02% | -88.1% |
| Q3 2020 | $8,071,000 | +125.9% | 100,355 | +141.8% | 0.14% | +36.2% |
| Q2 2020 | $3,573,000 | -77.7% | 41,496 | -78.9% | 0.10% | -72.7% |
| Q1 2020 | $16,004,000 | -45.9% | 197,123 | -44.3% | 0.38% | -37.7% |
| Q4 2019 | $29,602,000 | +27.0% | 354,012 | +32.9% | 0.62% | +4.2% |
| Q3 2019 | $23,302,000 | +69.4% | 266,403 | +58.6% | 0.59% | +115.6% |
| Q2 2019 | $13,759,000 | +74.5% | 168,000 | +73.2% | 0.28% | +35.5% |
| Q1 2019 | $7,887,000 | -19.8% | 97,000 | -35.1% | 0.20% | -15.8% |
| Q4 2018 | $9,831,000 | -11.2% | 149,366 | +4.0% | 0.24% | +20.5% |
| Q3 2018 | $11,067,000 | +4690.9% | 143,562 | +4498.4% | 0.20% | +4900.0% |
| Q2 2018 | $231,000 | -65.2% | 3,122 | -69.4% | 0.00% | -63.6% |
| Q1 2018 | $664,000 | -27.7% | 10,216 | -28.2% | 0.01% | -31.2% |
| Q4 2017 | $919,000 | -37.5% | 14,223 | -39.3% | 0.02% | -40.7% |
| Q3 2017 | $1,470,000 | -12.2% | 23,433 | -15.2% | 0.03% | +3.8% |
| Q2 2017 | $1,674,000 | +7.4% | 27,644 | -8.0% | 0.03% | +18.2% |
| Q1 2017 | $1,558,000 | +37.1% | 30,044 | +25.9% | 0.02% | +37.5% |
| Q3 2016 | $1,136,000 | +25.4% | 23,860 | +8.2% | 0.02% | +14.3% |
| Q1 2016 | $906,000 | +107.3% | 22,053 | +92.5% | 0.01% | +180.0% |
| Q4 2015 | $437,000 | -61.1% | 11,459 | -66.5% | 0.01% | -66.7% |
| Q3 2015 | $1,123,000 | – | 34,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |